Free Trial

Caitlin Cronin Analyst Performance

Director - MedTech Equity Research at Canaccord Genuity Group

Caitlin Cronin is a stock analyst at Canaccord Genuity Group focused in the medical sector, covering 10 publicly traded companies. Over the past year, Caitlin Cronin has issued 25 stock ratings, including buy and hold recommendations. While full access to Caitlin Cronin's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Caitlin Cronin's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
35 Last 1 Years
Buy Recommendations
69.70% 23 Buy Ratings
Companies Covered
10 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy69.7%23 ratings
Hold30.3%10 ratings
Sell0.0%0 ratings

Out of 33 total stock ratings issued by Caitlin Cronin at Canaccord Genuity Group, the majority (69.7%) have been Buy recommendations, followed by 30.3% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
70.0% of companies on NASDAQ
7 companies
NYSE
30.0% of companies on NYSE
3 companies

Caitlin Cronin, an analyst at Canaccord Genuity Group, currently covers 10 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
9 companies
90.0%
Manufacturing
1 company
10.0%

Caitlin Cronin of Canaccord Genuity Group specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
3 companies
30.0%
MED PRODUCTS
2 companies
20.0%
MED - BIOMED/GENE
2 companies
20.0%
MEDICAL SERVICES
1 company
10.0%
MEDICAL INFO SYS
1 company
10.0%
SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES
1 company
10.0%

Caitlin Cronin's Ratings History at Canaccord Genuity Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
5/11/2026Lower Price Target$29.47$30.00Hold
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
5/6/2026Lower Price Target$7.18$23.00Buy
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
4/24/2026Set Price Target$31.44$32.00
AxoGen, Inc. stock logo
AXGN
AxoGen
4/24/2026Set Price Target$37.22$45.00
AxoGen, Inc. stock logo
AXGN
AxoGen
3/30/2026Reiterated Rating$31.07$40.00Buy
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
3/5/2026Boost Price Target$34.78$35.00Hold
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2/26/2026Boost Price Target$77.20$90.00Buy
Globus Medical, Inc. stock logo
GMED
Globus Medical
1/9/2026Boost Price Target$94.48$112.00Buy
Enovis Corporation stock logo
ENOV
Enovis
12/17/2025Lower Price Target$27.48$50.00Buy
InMode Ltd. stock logo
INMD
InMode
12/17/2025Set Price Target$14.48$15.00Hold
Globus Medical, Inc. stock logo
GMED
Globus Medical
12/17/2025Boost Price Target$85.80$105.00Buy
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
12/17/2025Boost Price Target$74.15$85.00Buy
AxoGen, Inc. stock logo
AXGN
AxoGen
12/5/2025Boost Price Target$32.85$37.00Buy
TELA Bio, Inc. stock logo
TELA
TELA Bio
11/18/2025Lower Price Target$1.14$4.00Buy
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
11/11/2025Lower Price Target$33.35$34.00Hold
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
11/6/2025Boost Price Target$64.88$72.00Buy
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
10/31/2025Boost Price Target$16.33$25.00Buy
AxoGen, Inc. stock logo
AXGN
AxoGen
10/30/2025Boost Price Target$22.25$27.00Buy
InMode Ltd. stock logo
INMD
InMode
10/10/2025Boost Price Target$15.89$16.00Hold
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
8/20/2025Initiated Coverage$37.70$60.00Buy
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
8/18/2025Boost Price Target$36.20$36.00Hold
Enovis Corporation stock logo
ENOV
Enovis
8/8/2025Lower Price Target$28.49$58.00Buy
Alphatec Holdings, Inc. stock logo
ATEC
Alphatec
8/1/2025Reiterated Rating$13.51$20.00Buy
Vericel Corporation stock logo
VCEL
Vericel
8/1/2025Lower Price Target$35.63$58.00Buy
InMode Ltd. stock logo
INMD
InMode
7/11/2025Reiterated Rating$14.78$15.00Hold
Enovis Corporation stock logo
ENOV
Enovis
5/14/2025Lower Price Target$36.07$70.00Buy
AxoGen, Inc. stock logo
AXGN
AxoGen
5/13/2025Lower Price Target$11.27$24.00Buy
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
5/1/2025Boost Price Target$28.26$28.00Hold
InMode Ltd. stock logo
INMD
InMode
4/29/2025Lower Price Target$14.26$15.00Hold
TELA Bio, Inc. stock logo
TELA
TELA Bio
3/21/2025Lower Price Target$1.43$7.00Buy
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
3/17/2025Reiterated Rating$28.86$27.00Hold
Bioventus Inc. stock logo
BVS
Bioventus
3/17/2025Reiterated Rating$9.71$15.00Buy
AxoGen, Inc. stock logo
AXGN
AxoGen
2/26/2025Boost Price Target$19.70$26.00Buy
Vericel Corporation stock logo
VCEL
Vericel
2/3/2025Boost Price Target$58.54$67.00Buy
AxoGen, Inc. stock logo
AXGN
AxoGen
2/3/2025Boost Price Target$18.21$22.00Buy